132 related articles for article (PubMed ID: 6692425)
41. Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin.
Berg K; Dietze A; Kaalhus O; Høgset A
Clin Cancer Res; 2005 Dec; 11(23):8476-85. PubMed ID: 16322311
[TBL] [Abstract][Full Text] [Related]
42. In vitro and in vivo pharmacological characterizations of the antitumor properties of two new olivacine derivatives, S16020-2 and S30972-1.
Malonne H; Farinelle S; Decaestecker C; Gordower L; Fontaine J; Chaminade F; Saucier JM; Atassi G; Kiss R
Clin Cancer Res; 2000 Sep; 6(9):3774-82. PubMed ID: 10999772
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activity.
Baraldi PG; Cacciari B; Guiotto A; Romagnoli R; Spalluto G; Zaid AN; Cozzi P; Geroni C; Mongelli N
Farmaco; 1997 Dec; 52(12):711-6. PubMed ID: 9648274
[TBL] [Abstract][Full Text] [Related]
44. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and structure-activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues.
Shao Y; Ding H; Tang W; Lou L; Hu L
Bioorg Med Chem; 2007 Aug; 15(15):5061-75. PubMed ID: 17544278
[TBL] [Abstract][Full Text] [Related]
46. Criteria for selection of new analogs of antitumor antibiotics.
Goldin A
Recent Results Cancer Res; 1978; 63():99-112. PubMed ID: 705018
[TBL] [Abstract][Full Text] [Related]
47. [ BCG-immunotherapy and bladder cancer].
Rischmann P
Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
[No Abstract] [Full Text] [Related]
48. Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium.
Wang Y; Zhang L; Li Y; Hou X; Zeng F
Carbohydr Res; 2004 Oct; 339(15):2567-74. PubMed ID: 15476718
[TBL] [Abstract][Full Text] [Related]
49. [Results of a prospective study of chemoprophylaxis with alternating mitomycin-C and BCG: complete response and recurrence and progression index].
Nohales Taurines G; Cortadellas Angel R; Arango Toro O; Bielsa Gali O; Gelabert Mas A
Arch Esp Urol; 1996 Sep; 49(7):689-92. PubMed ID: 9020005
[TBL] [Abstract][Full Text] [Related]
50. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
51. [Cytostatic action of semisynthetic rubomycin derivatives].
Volkolupova OP; Makukho LV
Antibiotiki; 1982 Oct; 27(10):779-81. PubMed ID: 7149685
[TBL] [Abstract][Full Text] [Related]
52. [Studies on antineoplastic action of indirubin derivatives and analogs and their structure-activity relationships].
Ji XJ; Zhang FR
Yao Xue Xue Bao; 1985 Feb; 20(2):137-9. PubMed ID: 4036618
[No Abstract] [Full Text] [Related]
53. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Sakamoto N; Toge T; Nishiyama M
Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
[TBL] [Abstract][Full Text] [Related]
54. [Antitumor electro-chemotherapy].
Mir LM
Bull Cancer; 1994 Sep; 81(9):740-8. PubMed ID: 7535603
[TBL] [Abstract][Full Text] [Related]
55. Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo.
Chirigos MA; Stylos WA
Cancer Res; 1980 Jun; 40(6):1967-72. PubMed ID: 7371032
[TBL] [Abstract][Full Text] [Related]
56. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
[TBL] [Abstract][Full Text] [Related]
57. Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?
Dalbagni G
Eur Urol; 2009 Aug; 56(2):257-8; discussion 258-9. PubMed ID: 19427109
[No Abstract] [Full Text] [Related]
58. Synthesis of flavone-2'-carboxylic acid analogues as potential antitumor agents.
Valenti P; Bisi A; Rampa A; Gobbi S; Belluti F; Da Re P; Cima L; Carrara M
Anticancer Drug Des; 1998 Dec; 13(8):881-92. PubMed ID: 10335265
[TBL] [Abstract][Full Text] [Related]
59. [Antitumor antibiotics].
Suzuki T
Nihon Rinsho; 2015 Feb; 73 Suppl 2():188-90. PubMed ID: 25831749
[No Abstract] [Full Text] [Related]
60. [Use of different methods for the primary selection of antitumor antibiotics].
Ivanitskaia LP; Upiter GD
Antibiotiki; 1967 May; 12(5):369-74. PubMed ID: 5627678
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
